Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity

Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings, published in Cell on December 1, could have a clinical role in improving efficiency of immunotherapy drugs. … Read the Full Story from the UC San Diego Newsroom


Dennis Carson, MDThe study coauthors include Dennis A. Carson, MD, member of the UC San Diego Resident Faculty in the UC San Diego Stem Cell Program.

Dr. Carson is Emeritus Professor of Medicine in the Division of Rheumatology, Allergy, and Immunology and former Director of the Moores Cancer Center.